|1.||Ichise, Masanori: 4 articles (01/2010 - 08/2006)|
|2.||Marner, Lisbeth: 2 articles (04/2012 - 03/2012)|
|3.||Frokjaer, Vibe G: 2 articles (03/2012 - 01/2011)|
|4.||Knudsen, Gitte M: 2 articles (03/2012 - 01/2011)|
|5.||Rusjan, Pablo: 2 articles (09/2008 - 09/2007)|
|6.||Wilson, Alan A: 2 articles (09/2008 - 09/2007)|
|7.||Meyer, Jeffrey H: 2 articles (09/2008 - 09/2007)|
|8.||Houle, Sylvain: 2 articles (09/2008 - 09/2007)|
|9.||Manji, Husseini K: 2 articles (10/2007 - 08/2006)|
|10.||Gandhi, Shilpa K: 2 articles (10/2007 - 08/2006)|
|1.||Alzheimer Disease (Alzheimer's Disease)
04/01/2012 - "Furthermore, a PET study of patients with Alzheimer's disease with the serotonin transporter ligand [11C]DASB showed relatively preserved serotonergic projections, despite a marked decrease in 5-HT2A receptor binding. "
03/01/2012 - "Loss of serotonin 2A receptors exceeds loss of serotonergic projections in early Alzheimer's disease: a combined [11C]DASB and [18F]altanserin-PET study."
|2.||Obsessive-Compulsive Disorder (Disorder, Obsessive-Compulsive)
01/01/2010 - "Reduced serotonin transporter binding in the insular cortex in patients with obsessive-compulsive disorder: a [11C]DASB PET study."
01/01/2007 - "Reduced availability of serotonin transporters in obsessive-compulsive disorder correlates with symptom severity - a [11C]DASB PET study."
01/01/2016 - "Altered serotonin transporter binding potential in patients with obsessive-compulsive disorder under escitalopram treatment: [11C]DASB PET study."
|3.||Parkinson Disease (Parkinson's Disease)
|4.||Sleep Apnea Syndromes (Sleep Apnea)
|5.||Schizophrenia (Dementia Praecox)
06/15/2005 - "This study failed to detect alterations of SERT availability in patients with schizophrenia; however, this study does not rule out the possibility that schizophrenia might be associated with alterations of SERT density in the cortical regions, where the [11C]DASB-specific binding signal is too low for reliable quantification of SERT."
06/15/2005 - "Ten medication-free patients with schizophrenia and 10 healthy subjects underwent positron emission tomography (PET) scans for 90 min after 11C-3-amino-4-(2-dimethylaminomethylphenylthio)benzonitrile ([11C]DASB) injection. "
06/15/2005 - "Serotonin transporter availability in patients with schizophrenia: a positron emission tomography imaging study with [11C]DASB."
|1.||Serotonin Plasma Membrane Transport Proteins (Serotonin Transporter)
|2.||5-HT2A Serotonin Receptor (5 HT2A Receptor)
|3.||Serotonin (5 Hydroxytryptamine)
|6.||Serotonin Uptake Inhibitors (Serotonin Reuptake Inhibitors)